News
Geospace Technologies: Positive Signs Despite A Few Headwinds (NASDAQ:GEOS)
GEOS Is Gathering Steam My previous article on Geospace Technologies Corporation (NASDAQ:GEOS) discussed its business and strategies. In 2023, the…
Aldeyra (ALDX): Navigating The Future Of Eye Disease Treatment With Reproxalap
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases. Their groundbreaking RASP (reactive aldehyde…
Biogen And Alzheimer’s Disease: Too Early To Celebrate (NASDAQ:BIIB)
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB) and Eisai’s (OTCPK:ESALF, OTCPK:ESAIY) anti-amyloid…
Eli Lilly: The Party Is Likely Over (NYSE:LLY)
Investors in Eli Lilly and Company (NYSE:LLY) have benefited from its solid execution in its well-diversified portfolio and pipeline as…
Burberry: Shares Move Closer To Fair Value Amid Lingering Headwinds (OTCMKTS:BBRYF)
Luxury fashion house Burberry (OTCPK:BURBY) (OTCPK:BBRYF) was facing some headwinds when I last covered it just over a year ago,…
Green Thumb Industries: Future Catalysts Sum Up The Bull Case (OTCMKTS:GTBIF)
Investment Thesis Green Thumb Industries (OTCQX:GTBIF) is one of the largest US multi-state operators (MSO) in the cannabis industry. They…
S&P, Nasdaq, Dow’s Poor Construction; T-Bill Rates, Yield Curve Creep
Listen below or on the go on Apple Podcasts and Spotify. Matthew Tuttle and Rob Isbitts dissect the S&P, Nasdaq,…
Crocs: Sharp Execution Delivers Astounding Results And Returns, Easily Beating SPY.
The CROX Investment Thesis Remains Excellent, Despite The Rally Thus Far CROX 3Y Stock Return Trading View Crocs, Inc. (NASDAQ:CROX)…